To: | Progenics Pharmaceuticals, Inc. (botrademarks@klgates.com) |
Subject: | U.S. Trademark Application Serial No. 88647019 - PYLCISE - MIN.630.US |
Sent: | January 17, 2020 02:52:00 PM |
Sent As: | ecom103@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88647019
Mark: PYLCISE
|
|
Correspondence Address: |
|
Applicant: Progenics Pharmaceuticals, Inc.
|
|
Reference/Docket No. MIN.630.US
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: January 17, 2020
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. As agreed to by Ms. Phi Lan Tinsley on January 14, 2020, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id. In addition, applicant is advised that amendments to the goods and/or services are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods and/or services are not permitted. 37 C.F.R. §2.71(a).
IDENTIFICATION AND CLASSIFICATION OF SERVICES
See TMEP §§1402.01, 1402.01(e).
The identification of goods in International Class 5 is left unchanged by this amendment.
/tmm/
Theodore McBride
Law Office 103
theodore.mcbride1@uspto.gov
phone: 571-272-9281